MOCA Health supports practitioner-led telehealth consultation pathways for patients seeking healthcare guidance relating to a range of chronic and ongoing health circumstances.
Independent healthcare practitioners operating within Australian regulatory frameworks assess each patient individually according to:
healthcare history
current medications
individual healthcare circumstances
previous healthcare approaches
clinical judgement
applicable regulatory requirements
Consultations are conducted through secure telehealth systems and may involve broader healthcare discussions relating to regulated medicinal cannabis prescribing pathways where clinically appropriate.
Patients may seek practitioner consultations regarding a range of ongoing healthcare circumstances and symptom-related discussions.
Healthcare practitioners may consider factors including:
duration of healthcare concerns
previous treatment history
current healthcare management approaches
medication considerations
lifestyle and wellbeing factors
broader healthcare circumstances
All healthcare assessments are conducted independently by the consulting practitioner.
MOCA Health supports telehealth consultation accessibility for patients across Australia, including regional and remote areas.
Telehealth systems allow patients to access healthcare consultations remotely while maintaining appropriate professional and regulatory oversight.
Medicinal cannabis prescribing pathways in Australia operate within regulatory frameworks governed by organisations including the Therapeutic Goods Administration (TGA).
Where clinically appropriate, healthcare practitioners may consider:
Special Access Scheme (SAS) pathways
Authorised Prescriber pathways
regulated prescribing frameworks
licensed pharmacy dispensing pathways
All prescribing decisions remain subject to practitioner assessment, clinical judgement, and Australian regulatory requirements.
This website provides general educational information only and does not constitute medical advice.
Medicinal cannabis is not suitable for all patients and access pathways remain subject to practitioner assessment and regulatory requirements.
Consultations do not guarantee prescriptions, approvals, or treatment outcomes.